Ling Ding

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2020 · 1.2K citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +5

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang, Yuntao Zhang, Baoying Huang et al. · Cell · 2020 · 796 citations · Full text

Vaccination, Vaccine Development, Immunology +7

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2021 · 198 citations · Full text

Silver nanoparticles selectively induce human oncogenic γ-herpesvirus-related cancer cell death through reactivating viral lytic replication

Chunlei Wan, Jiahui Tai, Jie Zhang et al. · Cell Death and Disease · 2019 · 39 citations · Full text

Viral-Mediated AURKB Cleavage Promotes Cell Segregation and Tumorigenesis

Qing Zhu, Ling Ding, Zhenguo Zi et al. · Cell Reports · 2019 · 37 citations · Full text